Clinical Trial Update: Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating fisetin to improve fatigue in older adult cancer survivors. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fisetin (fisetin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Fatigue | Phase 4 | Status: RECRUITING